A detailed history of Union Savings Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Union Savings Bank holds 5,114 shares of ABBV stock, worth $986,286. This represents 0.46% of its overall portfolio holdings.

Number of Shares
5,114
Previous 5,697 10.23%
Holding current value
$986,286
Previous $1.04 Billion 15.45%
% of portfolio
0.46%
Previous 0.54%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$154.79 - $180.76 $90,242 - $105,383
-583 Reduced 10.23%
5,114 $877 Million
Q1 2024

Apr 29, 2024

SELL
$159.82 - $182.1 $20,776 - $23,673
-130 Reduced 2.23%
5,697 $1.04 Billion
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $29,584 - $33,318
215 Added 3.83%
5,827 $903 Million
Q3 2023

Oct 24, 2023

BUY
$133.59 - $154.65 $43,149 - $49,951
323 Added 6.11%
5,612 $837 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $700,845 - $872,156
5,289 New
5,289 $791 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $341B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Union Savings Bank Portfolio

Follow Union Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Union Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Union Savings Bank with notifications on news.